These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3550656

  • 1. Hallucinogens.
    Brown RT, Braden NJ.
    Pediatr Clin North Am; 1987 Apr; 34(2):341-7. PubMed ID: 3550656
    [Abstract] [Full Text] [Related]

  • 2. The hallucinogens and the inhalants.
    Cohen S.
    Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
    [Abstract] [Full Text] [Related]

  • 3. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB, MINER EJ, ISBELL H.
    Psychopharmacologia; 1962 Dec; 3():219-23. PubMed ID: 14007905
    [No Abstract] [Full Text] [Related]

  • 4. EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.
    HARTMAN AM, HOLLISTER LE.
    Psychopharmacologia; 1963 Aug 20; 4():441-51. PubMed ID: 14048565
    [No Abstract] [Full Text] [Related]

  • 5. Management of hallucinogen abuse.
    Haddad LM.
    Am Fam Physician; 1976 Jul 20; 14(1):82-7. PubMed ID: 1065215
    [Abstract] [Full Text] [Related]

  • 6. Mescaline, LSD, psilocybin, and personality change.
    UNGER SM.
    Psychiatry; 1963 May 20; 26():111-25. PubMed ID: 13995386
    [No Abstract] [Full Text] [Related]

  • 7. [Narcotics abuse in adolescents].
    Leuner H.
    Nervenarzt; 1971 Jun 20; 42(6):281-91. PubMed ID: 4931883
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
    LUDWIG AM, LEVINE J.
    JAMA; 1965 Jan 11; 191():92-6. PubMed ID: 14233246
    [No Abstract] [Full Text] [Related]

  • 10. Deceptions in the illicit drug market.
    Cheek FE, Newell S, Joffe M.
    Science; 1970 Feb 27; 167(3922):1276. PubMed ID: 5460848
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS.
    CHARALAMPOUS KD, KINROSS-WRIGHT J.
    Tex State J Med; 1963 Sep 27; 59():848-52. PubMed ID: 14054727
    [No Abstract] [Full Text] [Related]

  • 15. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J, Appel JB.
    Psychopharmacology (Berl); 1982 Sep 27; 76(2):130-5. PubMed ID: 6805022
    [Abstract] [Full Text] [Related]

  • 16. CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.
    HOLLISTER LE, SJOBERG BM.
    Compr Psychiatry; 1964 Jun 27; 5():170-8. PubMed ID: 14156873
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Habit forming drugs. 2. Hallucinogens].
    Kaij L.
    Lakartidningen; 1969 Nov 26; 66(48):4989-91. PubMed ID: 5371506
    [No Abstract] [Full Text] [Related]

  • 19. [The abuse of psychodelics: a social and medical problem].
    Nowak S, Herman Z.
    Pol Tyg Lek; 1970 May 11; 25(19):698-701. PubMed ID: 4912910
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.